Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects
Tóm tắt
Vitamin D deficiency is a major health problem which affects about one billion people in the world. Although, vitamin D supplementation is recommended as standard treatment of vitamin D deficiency, there are controversies on dose response relationship. In this regard, the present study aimed to determine the impact of vitamin D3 supplement on raising of serum 25 hydroxyvitamin D[25(OH)D] in healthy subjects with varying degrees of vitamin D deficiency. In this clinical trial 114 subjects with varying degrees of vitamin D deficiency were entered and divided into three groups: serum levels of 25(OH) D less than 10 ng/ml, 10–20 ng/ml, and 20–30 ng/ml. All of the participants were given 50,000 units vitamin D3 per week for 8 weeks, thereafter, changes in serum levels of vitamin D and PTH were evaluated at week twelve. The results were analyzed using SPSS version 16 and P < 0.05 was considered to be significant. Of the 114 vitamin D deficient subjects, serum level of vitamin D was below 10 ng/ml in 22 persons (19.3%), 10–20 ng/ml in 52 persons (45.6%) and 20–30 ng/ml in 40 persons (35.1%). Following vitamin D prescription all people with varying degrees of vitamin D deficiency obtained a favorable serum level. The increase in vitamin D levels were 26.4, 18.5, and 8.3 ng/ml, in individuals with baseline vitamin D levels below 10 ng/ml, 10–20 ng/ml and 20–30 ng/ml, respectively. The changes in 25(OH) vitamin D in all three groups were significant (P < 0.05), nonetheless no significant alterations in serum levels of PTH were observed (P > 0.05). Our results indicated an inverse relationship between baseline serum levels of 25(OH) D and its increment following treatment with vitamin D3. Therefore, the magnitude of increments in serum 25(OH) D is greater in subjects with lower baseline levels of 25(OH) D.
Tài liệu tham khảo
R. Lin, J.H. White, The pleiotropic actions of vitamin D. Bioessays 26, 21–28 (2004)
M.A. Kaykhaei, M. Hashemi, B. Narouie, A. Shikhzadeh, H. Rashidi, N. Moulaei, S. Ghavami, High prevalence of vitamin D deficiency in Zahedan, southeast Iran. Ann. Nutr. Metab. 58, 37–41 (2011)
S.H. Masood, M.P. Iqbal, Prevalence of vitamin D deficiency in South Asia. Angiogenesis 1, 12 (2008)
M.F. Holick, Vitamin D deficiency. N. Engl. J. Med 357, 266–281 (2007)
M.F. Holick, in Evolution and Function of Vitamin D. In: Reichrath J., Tilgen W., Friedrich M. (eds). Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. (Springer, Berlin, Heidelberg, 2003) pp. 3–28
J.S.R.B. Adams, S. Witzel, R.E. Reyes, A. Shieh, R. Chun et al. Regulation of the extrarenal CYP27B1-hydroxylase. J. Steroid Biochem. Biol. 144, 22–27 (2014)
H.A.P. Harant, G.S. Reddy, E. Foglar, I.J.D. Lindley, 1 alpha,25-dihydroxyvitamin D-3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappa B-mediated interleukin-8 gene expression. Eur. J. Biochem. 250, 63–71 (1997)
J.R. Sabetta, P. DePetrillo, R.J. Cipriani, J. Smardin, L.A. Burns, M.L. Landry, Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 5, e11088 (2010)
M. Juonala, A. Voipio, K. Pahkala, J.S. Viikari, V. Mikkilä, M. Kähönen, N. Hutri-Kähönen, A. Jula, D. Burgner, M.A. Sabin, Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. The. J. Clin. Endocrinol. Metab. 100, 1469–1476 (2015)
B. Rhead, M. Bäärnhielm, M. Gianfrancesco, A. Mok, X. Shao, H. Quach, L. Shen, C. Schaefer, J. Link, A. Gyllenberg, Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol. Genet. 2, e97 (2016)
C. Annweiler, Y. Rolland, A.M. Schott, H. Blain, B. Vellas, F.R. Herrmann, O. Beauchet, Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: a 7-year follow-up. J. Gerontol. Ser. A 67, 1205–1211 (2012)
R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J.C. Kiefte-de-Jong, H. Khan, C.P. Baena, D. Prabhakaran, M.B. Hoshen, Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903 (2014)
P. Bergman, A.-C. Norlin, S. Hansen, R.S. Rekha, B. Agerberth, L. Björkhem-Bergman, L. Ekström, J.D. Lindh, J. Andersson, Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2, e001663 (2012)
A.-C. Norlin, S. Hansen, E. Wahren-Borgström, C. Granert, L. Björkhem-Bergman, P. Bergman, Vitamin D3 supplementation and antibiotic consumption–results from a prospective, observational study at an immune-deficiency unit in Sweden. PLoS ONE 11, e0163451 (2016)
P. Pludowski, M.F. Holick, S. Pilz, C.L. Wagner, B.W. Hollis, W.B. Grant, Y. Shoenfeld, E. Lerchbaum, D.J. Llewellyn, K. Kienreich, Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun. Rev. 12, 976–989 (2013)
J.-C. Souberbielle, J.-J. Body, J.M. Lappe, M. Plebani, Y. Shoenfeld, T.J. Wang, H.A. Bischoff-Ferrari, E. Cavalier, P.R. Ebeling, P. Fardellone, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev. 9, 709–715 (2010)
J. Lappe, D. Travers-Gustafson, K. Davies, R. Recker, R. Heaney, Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial (American Journal of Clinical Nutrition (2007) 85,(1586–1591)). Am. J. Clin. Nutr. 87, 794 (2008)
P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2, 76–89 (2014)
E. Theodoratou, I. Tzoulaki, L. Zgaga, J.P. Ioannidis, Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035 (2014)
R. Scragg, Emerging evidence of thresholds for beneficial effects from vitamin D supplementation. Nutrients 10, 561 (2018)
S. Spedding, S. Vanlint, H. Morris, R. Scragg, Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 5, 5127–5139 (2013)
R. Bouillon, Comparative analysis of nutritional guidelines for vitamin D. Nat. Rev. Endocrinol 13, 466–479 (2017)
L.B.F. Cianferotti, H.A. Bischoff-Ferrari, O. Bruyere, C. Cooper, M. Cutolo, J.A. Kanis, J.M. Kaufman, J.Y. Reginster, R. Rizzoli, M.L. Brandi, Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Endocrine 56, 245–261 (2017)
P. Płudowski, E. Karczmarewicz, M. Bayer, G. Carter, D. Chlebna-Sokół, J. Czech-Kowalska, R. Dębski, T. Decsi, A. Dobrzańska, E. Franek, Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe—recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol. Pol. 64, 319–327 (2013)
M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011)
A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011)
A. Haq, S.J. Wimalawansa, P. Pludowski, F. Al Anouti, Clinical practice guidelines for vitamin D in the United Arab Emirates. J. Steroid Biochem. Mol. Biol. 175, 4–11 (2016)
P. Byrne, R. Freaney, M. McKenna, Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes. Calcif. Tissue Int. 56, 518–520 (1995)
V. Chel, M. Ooms, C. Popp‐Snijders, S. Pavel, A. Schothorst, C. Meulemans, P. Lips, Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J. Bone Miner. Res. 13, 1238–1242 (1998)
M.A.J. Kyriakidou-Himonas, J.K. Yeh, Vitamin D supplementation in postmenopausal black women. J. Clin. Endocrinol. Metab. 84, 3988–3990 (1999)
R.P. Heaney, K.M. Davies, T.C. Chen, M.F. Holick, M.J. Barger-Lux, Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003)
J.C. Gallagher, A. Sai, T. Templin, L. Smith, Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann. Intern. Med. 156, 425–437 (2012)
P. Autier, S. Gandini, P. Mullie, A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J. Clin. Endocrinol. Metab. 97, 2606–2613 (2012)
A. Drincic, E. Fuller, R.P. Heaney, L.A. Armas, 25-Hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults. J. Clin. Endocrinol. Metab. 98, 4845–4851 (2013)
H.M. Trang, D. Cole, L.A. Rubin, A. Pierratos, S. Siu, R. Vieth, Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr. 68, 854–858 (1998)
J.M. Quesada-Gomez, Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos. Int. 29, 1697–1711 (2018)
A. Shieh, C. Ma, R.F. Chun, J. Wittwer-Schegg, L. Swinkels, T. Huijs, J. Wang, I. Donangelo, M. Hewison, J.S. Adams, Associations between change in total and free 25-hydroxyvitamin D with 24, 25-dihydroxyvitamin D and parathyroid hormone. J. Clin. Endocrinol. Metab. 8, e1187349 (2018)
H. Ketha, T.D. Thacher, S.S. Oberhelman, P.R. Fischer, R.J. Singh, R. Kumar, Comparison of the effect of daily versus bolus dose maternal vitamin D3 supplementation on the 24, 25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio. Bone 110, 321–325 (2018)
T.J. Wang, F. Zhang, J.B. Richards, B. Kestenbaum, J.B. Van Meurs, D. Berry, D.P. Kiel, E.A. Streeten, C. Ohlsson, D.L. Koller, Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180–188 (2010)
A. Bakhshipour, M.A. Kaykhaei, N. Moulaei, M.A. Mashhadi, Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. Arab J. Gastroenterol. 14, 113–115 (2013)
J.P. Ekwaru, J.D. Zwicker, M.F. Holick, E. Giovannucci, P.J. Veugelers, The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE 9, e111265 (2014)
S.M. Pietras, B.K. Obayan, M.H. Cai, M.F. Holick, Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch. Intern. Med. 169, 1806–1818 (2009)
R. Vieth, P.-C.R. Chan, G.D. MacFarlane, Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level–. Am. J. Clin. Nutr. 73, 288–294 (2001)
R.A. Durazo-Arvizu, B. Dawson-Hughes, H. Kramer, G. Cao, J. Merkel, P.M. Coates, C.T. Sempos, The reverse J-shaped association between serum total 25-hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization. Am. J. Epidemiol. 185, 720–726 (2017)
P.G.-J.A. Caillet, M. Viprey, A.M. Schott, Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study. Sci. Rep. 7, 10361 2017)